Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.47 |
| ▸ | CASP7 | P55210 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | INMT | O95050 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9142016 | 0.88 | NOTUM (0.49) | NOTUMKDM4EALDH1A1ALOX15CASP1 | |
| SCHEMBL9628981 | 0.86 | NOTUM (0.47) | NOTUMKDM4EALDH1A1ALOX15CASP1 | |
| SCHEMBL627227 | 0.78 | MAOA (0.46) | NOTUMKDM4EALDH1A1MAOAMAPT | |
| Hydrochloric Acid SCHEMBL11512355 | 0.77 | MAOA (0.45) | NOTUMKDM4EALDH1A1MAOAMAPT | |
| Iodide SCHEMBL9188780 | 0.77 | MAOA (0.45) | NOTUMKDM4EALDH1A1MAOAMAPT | |
| Bromide SCHEMBL9694609 | 0.77 | MAOA (0.45) | NOTUMKDM4EALDH1A1MAOAMAPT | |
| Iodide SCHEMBL2234376 | 0.77 | MAOA (0.45) | NOTUMKDM4EALDH1A1MAOAMAPT | |
| SCHEMBL7561562 | 0.76 | NOTUM (0.53) | NOTUMKDM4EALDH1A1MAPTTP53 | |
| SCHEMBL7258139 | 0.76 | POLB (0.50) | NOTUMKDM4EALDH1A1MAPTTP53 | |
| SCHEMBL3315465 | 0.75 | NOTUM (0.51) | NOTUMKDM4EALDH1A1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024033479-A1 | (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | REMYND N.V. (BE) | 2024-02-15 | — | — | WO | disclosed |
| US-11786575-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11697695-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2023-07-11 | — | — | US | disclosed |
| US-11697695-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2023-07-11 | — | — | US | disclosed |
| US-20230124361-A1 | SMALL MOLECULE STING ANTAGONISTS | CURADEV PHARMA PVT. LTD. (IN) | 2023-04-20 | — | — | US | disclosed |
| WO-2023011656-A1 | FLUORESCENT DYE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 纳莹(上海)生物科技有限公司 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023011657-A1 | METHOD FOR DETECTING AND QUANTIFYING RNA | 纳莹(上海)生物科技有限公司 | 2023-02-09 | — | — | WO | disclosed |
| WO-2023011658-A1 | METHOD FOR DETECTING AND QUANTIFYING RNA | 纳莹(上海)生物科技有限公司 | 2023-02-09 | — | — | WO | disclosed |
| US-11186669-B2 | Polymerizable composition and optically anisotropic body using same | DIC CORPORATION (JP) | 2021-11-30 | — | — | US | disclosed |
| US-20210284766-A1 | RETARDATION FILM, ELLIPTICALLY POLARIZING PLATE, AND DISPLAY DEVICE INCLUDING THE SAME | DIC CORPORATION (JP) | 2021-09-16 | — | — | US | disclosed |
| US-20070105847-A1 | 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes | CADILA HEALTHCARE LIMITED (IN) | 2007-05-10 | — | — | US | disclosed |
| US-7183304-B2 | such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents | NOVARTIS AG (CH) | 2007-02-27 | — | — | US | disclosed |
| US-20070031336-A1 | 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof | NOVARTIS AG (CH) | 2007-02-08 | — | — | US | disclosed |
| US-20070021509-A1 | Phosphate transport inhibitors | JOZEFIAK THOMAS H | 2007-01-25 | — | — | US | disclosed |
| EP-1658294-B1 | 3H-PHENOXAZINE DERIVATIVES SUITABLE AS NEAR-INFRARED IMAGING AGENTS, PREPARATION AN USE THEREOF | NOVARTIS AG (CH) | 2007-01-10 | — | — | EP | disclosed |
| US-20070004704-A1 | Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X | NOVARTIS AG (CH) | 2007-01-04 | — | — | US | disclosed |
| EP-1658294-A1 | 3H-PHENOXAZINE DERIVATIVES SUITABLE AS NEAR-INFRARED IMAGING AGENTS, PREPARATION AN USE THEREOF | Novartis AG (CH) | 2006-05-24 | — | — | EP | disclosed |
| US-6884806-B2 | Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-04-26 | — | — | US | disclosed |
| WO-2005016934-A1 | 3H-PHENOXAZINE DERIVATIVES SUITABLE AS NEAR-INFRARED IMAGING AGENTS, PREPARATION AN USE THEREOF | NOVARTIS AG (CH) | 2005-02-24 | — | — | WO | disclosed |
| WO-2003055856-A2 | BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-07-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786575-B2 | Endoparasitic depsipeptides | VIP, PREP, NGLY1 | NOTUM 3584/4885KDM4E 3941/4885ALDH1A1 3102/4885 |
| US-20230124361-A1 | SMALL MOLECULE STING ANTAGONISTS | STING1, CGAS, MAVS | NOTUM 4275/4885KDM4E 3623/4885ALDH1A1 3672/4885 |
| US-20070004704-A1 | Such as 6-Methyl-2-[4-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-benzenesulfonylamino]-benzoic acid which binds Peroxisome Proliferator-Activated Receptors; conditions in which impaired glucose tolerance, hyperglycemia and insulin resistance are implicated, such as type-1 and type-2 diabetes, and Syndrome X | PPARG, GPR119, PPARA | NOTUM 3964/4885KDM4E 1746/4885ALDH1A1 845/4885 |
| US-20070031336-A1 | 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof | PSEN1, PSEN2, CHRM5 | NOTUM 3396/4885KDM4E 2578/4885ALDH1A1 4429/4885 |
| US-20070021509-A1 | Phosphate transport inhibitors | SLC34A2, SLC34A1, SLC20A1 | NOTUM 2402/4885KDM4E 4457/4885ALDH1A1 2163/4885 |
| US-20070105847-A1 | 1,3-Dioxane derivatives and analogues thereof useful in the treatment of i.a. obesity and diabetes | GPR119, PPARG, FABP4 | NOTUM 2047/4885KDM4E 3041/4885ALDH1A1 259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.